Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

316
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
316
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

525
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
525
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mandarin speech-based early detection of SCD: a feature-fusion residual network method.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Structure and druggable conformation of the homodimeric lipoprotein transporter of Acinetobacter baumannii.

Nature communications·2026
Same author

Plasma proteome and autism spectrum disorder: Integrative proteome-wide Mendelian randomization with clinical profiling.

Neurobiology of disease·2026
Same author

Autoimmune encephalitis associated with antibodies against intracellular antigens in children.

Frontiers in immunology·2026
Same author

Exploring the potential association between dietary factors and autism spectrum disorder: a Mendelian randomization analysis and retrospective study.

Frontiers in nutrition·2026
Same author

A complexity-to-diversity strategy for andrographolide derivatization and discovery of potential antiviral and anticancer scaffolds.

Organic & biomolecular chemistry·2025

相关实验视频

Updated: Jan 7, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

MEDL-DDI:以示例驱动的学习与多源特征来预测药物相互作用.

Haixue Zhao, Yunjiong Liu, Peiliang Zhang

    IEEE journal of biomedical and health informatics
    |December 26, 2025
    PubMed
    概括
    此摘要是机器生成的。

    这项研究引入了一种用于药物相互作用 (DDI) 预测的新框架,通过整合多样化的药物数据和解决阶级不平衡来提高准确性. 这种新方法,MEDL-DDI,在预测相互作用方面表现出卓越的表现.

    更多相关视频

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K

    相关实验视频

    Last Updated: Jan 7, 2026

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K

    科学领域:

    • 药理学 药理学是指药理学的学科.
    • 计算化学计算化学
    • 生物信息学是一种生物信息学.

    背景情况:

    • 准确的药物相互作用 (DDI) 预测对于安全有效的组合疗法至关重要.
    • 当前的DDI预测方法往往无法整合结构和序列药物信息,导致性能不佳.
    • 数据集中的类不平衡构成了重大挑战,使预测模型偏向于不太频繁的交互.

    研究的目的:

    • 为DDI预测开发一个强大的多式联络融合框架,整合结构和序列药物信息.
    • 为了应对DDI预测数据集中阶级不平衡的挑战.
    • 提高药物相互作用预测的准确性和可靠性.

    主要方法:

    • 为DDI (MEDL-DDI) 提出了一个多源示例驱动的学习框架.
    • 综合结构和序列药物表示通过多模式融合.
    • 利用化学知识丰富,全球语义特征的变压器,子结构的图形信息瓶,以及处理阶级不平衡的以实例为导向的机制.

    主要成果:

    • 与最先进的方法相比,MEDL-DDI在三个基准数据集上表现出更高的性能.
    • 该框架有效地整合了多式联络药物信息,以提高预测准确度.
    • 以示例驱动的机制成功地减轻了由阶级不平衡引起的预测偏差.

    结论:

    • 通过利用多模式数据融合和解决阶级不平衡,MEDL-DDI提供了一种强大的方法来准确预测药物相互作用.
    • 该框架显示了优化组合疗法和提高患者安全的巨大潜力.
    • 一个关于心血管药物的案例研究证实了MEDL-DDI的实际价值和适用性.